Skip to main content
logo
Alnylam Pharmaceuticals, Inc. (BMV:ALNY)
Mexico flag Mexico · Delayed Price · Currency is MXN
8,380.00
-180.00 (-2.10%)
At close: Sep 2, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other - Collaboration Revenue (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
Other - Collaboration Revenue (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Novartis AG - Collaboration
79.76M
Log In
Log In
Log In
Log In
Upgrade
Novartis AG - Collaboration Growth
-
Log In
Log In
Log In
Log In
Upgrade
Vir Biotechnology - Collaboration
-
Log In
Log In
Log In
Log In
Upgrade
Vir Biotechnology - Collaboration Growth
-
Log In
Log In
Log In
Log In
Upgrade
ONPATTRO
252.86M
Log In
Log In
Log In
Log In
Upgrade
ONPATTRO Growth
-32.12%
Log In
Log In
Log In
Log In
Upgrade
GIVLAARI
255.87M
Log In
Log In
Log In
Log In
Upgrade
GIVLAARI Growth
21.35%
Log In
Log In
Log In
Log In
Upgrade
Regeneron Pharmaceuticals - Collaboration
302.80M
Log In
Log In
Log In
Log In
Upgrade
Regeneron Pharmaceuticals - Collaboration Growth
-52.07%
Log In
Log In
Log In
Log In
Upgrade
OXLUMO
167.05M
Log In
Log In
Log In
Log In
Upgrade
OXLUMO Growth
19.37%
Log In
Log In
Log In
Log In
Upgrade
Royalty
91.79M
Log In
Log In
Log In
Log In
Upgrade
Royalty Growth
108.88%
Log In
Log In
Log In
Log In
Upgrade
AMVUTTRA
970.45M
Log In
Log In
Log In
Log In
Upgrade
AMVUTTRA Growth
79.78%
Log In
Log In
Log In
Log In
Upgrade
Roche - Collaboration
119.49M
Log In
Log In
Log In
Log In
Upgrade
Roche - Collaboration Growth
-85.17%
Log In
Log In
Log In
Log In
Upgrade
Other
8.18M
Log In
Log In
Log In
Log In
Upgrade